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ABSTRACT
Background: Murine boundary cap-derived neural crest stem cells (NCSCs) are capable of enhancing
islet function by stimulating beta cell proliferation as well as increasing the neural and vascular density
in the islets both in vitro and in vivo. This study aimed to isolate NCSC-like cells from human
bone marrow.
Methods: CD271 magnetic cell separation and culture techniques were used to purify a NCSC-
enriched population of human bone marrow. Analyses of the CD271þ and CD271- fractions in terms
of protein expression were performed, and the capacity of the CD271þ bone marrow cells to form
3-dimensional spheres when grown under non-adherent conditions was also investigated. Moreover,
the NCSC characteristics of the CD271þ cells were evaluated by their ability to migrate toward human
islets as well as human islet-like cell clusters (ICC) derived from pluripotent stem cells.
Results: The CD271þ bone marrow population fulfilled the criterion of being multipotent stem cells,
having the potential to differentiate into glial cells, neurons as well as myofibroblasts in vitro. They
had the capacity to form 3-dimensional spheres as well as an ability to migrate toward human islets,
further supporting their NCSC identity. Additionally, we demonstrated similar migration features
toward stem cell-derived ICC.
Conclusion: The results support the NCSC identity of the CD271-enriched human bone marrow popu-
lation. It remains to investigate whether the human bone marrow-derived NCSCs have the ability to
improve transplantation efficacy of not only human islets but stem cell-derived ICC as well.
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Introduction
Clinical islet transplantation is an alternative treatment for a
subgroup of type 1 diabetes patients suffering from severe
hypoglycemic attacks and can temporarily cure the disease.
However, the islet transplantation has its limitations since it
requires lifelong immunosuppressive therapy, which comes
with a number of complications (1). Although the results
after islet transplantation are improving, the success rate is
still not optimal, and insulin independence at 5 years post-
transplantation is 50% at best (2–5). Several factors contrib-
ute to the loss of graft viability and function after transplant-
ation, such as a defective engraftment process, including
poor revascularization, as well as an unsuitable microenviron-
ment at the transplantation site (6–10). Poor oxygenation of
the islets and amyloid formation result in cell dysfunction
and even cell death, contributing to the declining function
of the graft over time (11–14).
New ways to improve islet engraftment are needed in
order to make islet transplantation more successful. Several
approaches, including stem cell stimulation (mesenchymal
stem cells being the most extensively studied) as well as the
use of alternative islet implantation sites, have been eval-
uated (15–17). We have previously shown that neural crest
stem cells (NCSCs) from murine boundary cap have positive
effects on islets after co-culture and transplantation.
Moreover, co-culture and transplantation of murine NCSCs in
combination with murine or human islets were shown to
stimulate beta cell proliferation and increase the neural and
vascular density in the islets both in vitro and in vivo. NCSCs,
in contrast to mesenchymal stem cells, may potently stimu-
late beta cell proliferation and improve re-innervation
(18–21). However, difficulties with the clinical implementation
of murine NCSCs have prompted the investigation of an
adult human source of NCSCs with similar characteristics.
Nagoshi et al. were the first to report the presence of
NCSCs in the bone marrow of adult rodents, suggesting that
a portion of the mesenchymal stem cells in the bone marrow
is of neural crest lineage (22). Limited evidence exists regard-
ing their correspondence in human bone marrow (23).
Mesenchymal stem cells have been described to constitute
0.001-0.01% of bone marrow, and NCSCs are suggested to
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be a portion of these, consequently making it a real chal-
lenge to purify the NCSC population (24).
Low-affinity nerve growth factor receptor (CD271 or
P75NTR) is a common receptor of neurotrophins and is
required for the development and survival of peripheral neu-
rons. It is widely expressed in the developing nervous system
and is expressed by many neuronal cell types, including
NCSCs (25,26). CD271 enrichment has been used for selec-
tion of both multipotent mesenchymal stem cells as well as
NCSCs (27,28).
In the present study, we tested the hypothesis that
human bone marrow could be used as a source of adult
NCSC-derived cells. We investigated the potential of using
magnetic cell separation with CD271 microbeads to label
adult bone marrow NCSCs with high purity, suggesting that
a positive selection would result in a more NCSC-like popula-
tion of human bone marrow stromal cells. Moreover, forma-
tion of spheres has classically been used to enrich and test
NCSC-like potential (29). As evidence of the NCSC-like prop-
erties of the CD271þ cell population, we assessed sphere
generation and neuronal differentiation potential, both
previously described as characteristic of NCSCs. Furthermore,
studies suggest that the NCSC-stimulation of beta cell prolif-
eration can only be prompted in direct contact with islets,
and this through mutual migration (30,31). Since migration
capacity appears to be a vital NCSC characteristic in this
case, we investigated the migration behavior of the CD271þ
cells, not only toward islets but toward islet-like cell clusters
(ICC) as well. ICC derived from pluripotent stem cells is a
promising candidate for beta cell replacement therapies
(32,33). Due to the rapid progress and development of these
cells, we decided to investigate the migration capacity of
CD271þ cells toward ICC as well, postulating that migration
tendencies toward ICC could ultimately result in posi-
tive effects.
Materials and methods
Ethics approval
The study was approved by the Regional Ethics Review
Board, Uppsala, Sweden (2013/196; 2017/283). Informed con-
sent was obtained from all participants included in
the study.
Human islets
Human islets were generously provided from the human islet
isolation facility of the Nordic Network for Islet
Transplantation (Rudbeck Laboratory, Uppsala University
Hospital, Uppsala, Sweden). Islets were handpicked and cul-
tured free-floating in CMRL 1066 medium (Thermo Fisher
Scientific, Waltham, MA, USA) supplemented with L-glutam-
ine (2mmol/L; Sigma-Aldrich, St Louis, MO, USA), benzylpeni-
cillin (100U/mL; Roche Diagnostics, Scandinavia, Bromma,
Sweden), and 10% fetal calf serum (Sigma-Aldrich) at 37 C in
a humidified incubator with 5% CO2 and 95% air.
Human ICC derived from stem cells
Human ICC were differentiated as described previously (34),
with the following modifications: cells were dislodged and
dissociated during stage 4 and seeded in AggreWellTM400
(STEMCELL Technologies, Vancouver, BC, Canada) to form
uniform aggregates with similar size. During stage 6, the
aggregates were dislodged from the AggreWells and cul-
tured in suspension during the rest of the differentiation
protocol. The time points and components were optimized
during stages 6 and 7 to generate functional beta cells in
vitro (Table 1).
For morphological characterization, the ICC were fixed
with 4% paraformaldehyde, sectioned, and stained for immu-
nohistochemistry. Cryosections (7 lm) were stained with pri-
mary antibodies for insulin (polyclonal guinea pig, dilution
1:400; Fitzgerald, Acton, MA, USA), somatostatin (polyclonal
rabbit, dilution 1:400; Dako North America Inc., Carpinteria,
CA, USA), and glucagon (mouse biotin-conjugated, dilution
1:200; Thermo Fisher Scientific) and incubated at 4 C over-
night. Thereafter, secondary antibodies were applied and
incubated for 1 h at room temperature. Secondary antibodies
used were Alexa Fluor 488 anti-guinea pig (1:300; Jackson
Immunoresearch Laboratory, West Grove, PA, USA), Alexa
Fluor 647 donkey anti-rabbit (1:300; Jackson Immunoresearch
Laboratory), and CyTM3-conjugated streptavidin (1:300;
Jackson Immunoresearch Laboratory), respectively. Nuclei
were stained with Hoechst (1:10,000; Thermo Fisher
Scientific) and coverslips mounted with Fluorescence
Mounting Medium (Dako North America Inc.).
Preparation of NCSCs
Bone marrow aspirate was obtained from the posterior iliac
crest of five healthy male volunteers aged 19–69 (median
age 26 years). Mononuclear cells from bone marrow aspirate
were first isolated with SepMate PBMC isolation tubes
(STEMCELL Technologies) according to the manufacturer’s
instructions. The supernatant was discarded and the pellet
Table 1. Differentiation protocol to generate ICC from human pluripotent
stem cells (hPSCs).
Monolayer Suspension
ST1 ST2 ST3 ST4 ST5 ST6 ST7
(3 d) (3 d) (2 d) (3 d) (4 d) (14 d) (14 d)
AA
CHIR
Vit C
FGF7
Vit C
FGF7
SANT1
RA
LDN
TBP
EGF
Nic
AA
SANT1
RA
LDN
GC1
GSiXX
ALK5i
BTC
SANT1
RA
LDN
GC1
GSiXX
ALK5i
BTC
LDN
GC1
GSiXX
ALK5i
T3
ZM
NAC
AA: activin A; ALK5i: selective inhibitor of TGFbR-1/ALK5; BTC: betacellulin;
CHIR: CHIR-99021 GSK-3 inhibitor; EGF: epidermal growth factor; FGF7: fibro-
blast growth factor 7; GC1: high-affinity thyroid receptor a (TRa) and TRb
agonist; GSiXX: c-secretase inhibitor; LDN: LDN-193189 Alk inhibitor; NAC: N-
acetylcysteine; Nic: nicotinamide; RA: retinoid acid; SANT1: N-(4-benzylpipera-
zin-1-yl)-1-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methanimine; ST1-7: Stage
1–7; T3: liothyronine; TBP: alpha-amyloid precursor protein modulator; Vit C:
ascorbic acid; ZM: ZM 447439 Aurora inhibitor.
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re-suspended in alpha-MEM medium (Thermo Fisher
Scientific) with 10% mesenchymal stem cell fetal bovine
serum (MSC FBS; Thermo Fisher Scientific) and 1% penicillin-
streptomycin solution (Thermo Fisher Scientific) and seeded
in 75 cm2 flasks at approximately 800,000 cells/flask at 37 C
in 5% CO2 and 95% air. Since stromal cells are known to
adhere to plastic, subsequent plastic adherence technique
and culture followed. Cells were allowed to adhere and
propagate. The medium was changed every other day. After
10–14 days, when the cells were confluent, the cells were
dispersed into single cells using TrypLE Express (1X; Thermo
Fisher Scientific). CD271þ cells were separated from the sin-
gle cell suspension using the CD271 MicroBead Kit according
to the manufacturer’s instructions (Miltenyi Biotec, Auburn,
CA, USA). The CD271þ cells were magnetically labeled with
CD271 MicroBeads. The cell suspension was put into a MACS
column (Miltenyi Biotec), which was placed in the magnetic
field of a MACS Separator (Miltenyi Biotec). The labeled
CD271þ cells were retained in the column while the nega-
tive cells passed though. The cells were manually counted
before and after magnetic separation, and the fraction of
CD271þ cells was calculated and is presented as
mean± SEM. The CD271þ cells were seeded in 75 cm2 flasks
at approximately 500,000 cells/flask and cultured in DMEM/
F12 medium (1:1; Thermo Fisher Scientific) supplemented
with B27 (20 ng/mL; Thermo Fisher Scientific), N2 (20 ng/mL;
Thermo Fisher Scientific), epidermal growth factor (EGF;
20 ng/mL; R&D Systems, Minneapolis, MN, USA), and basic
fibroblast growth factor (bFGF; 20 ng/mL; R&D Systems),
which has been shown to further promote the NCSC propa-
gation (35). The medium was changed every second day
until the cells grew confluent. All experiments were carried
out on cells at passages 1–4.
Portions of the bone marrow cells, both before and after
separation, were seeded onto coverslips in a 24-well plate to
evaluate the magnetic cell separation. Coverslips were first pre-
treated in a 24-well plate for 10min at 37 C with poly-L-ornitin
(Sigma-Aldrich) followed by washing with Milli-Q water and
coating with laminin (20lg/mL; Sigma-Aldrich) at 37 C for a
minimum of 4h. A single cell suspension was prepared using
TrypLE Express (Thermo Fisher Scientific), and approximately
50,000 cells were seeded into each well. After culture for
approximately 1 week, the coverslips were washed with PBS
(Thermo Fisher Scientific), fixed with 4% paraformaldehyde and
incubated with primary antibody anti-nerve growth factor
receptor (P75NTR) (rabbit polyclonal, dilution 1:250; Merck
Millipore, Burlington, MA, USA) at 4 C overnight. Secondary
antibody Alexa Fluor 488 donkey anti-rabbit diluted 1:500
(Thermo Fisher Scientific) was added, and the coverslips with
attached cells were incubated for 1h in room temperature.
Nuclei were stained with Hoechst (1:10,000; Thermo Fisher
Scientific) and coverslips mounted with Fluorescence Mounting
Medium (Dako North America Inc.).
Functional characterization
For differentiation and functional characterization of the
CD271þ and CD271 bone marrow cells, coverslips were
pretreated and coated as described above. A single cell sus-
pension of the cells was prepared using TrypLE Express
(Thermo Fisher Scientific), and approximately 50,000 cells
were seeded into each well. Thereafter, 2mL of differenti-
ation medium were added to the wells. Cells were cultured
for at least 7 days. The differentiation medium consisted of
50% DMEM/F12, 50% neurobasal (Thermo Fisher Scientific)
supplemented with N2 and B27 and was changed every
other day. After culture, the coverslips were washed with
PBS (Thermo Fisher Scientific), fixed with 4% paraformalde-
hyde, and immunostainings were performed in the same
manner as described above. Primary antibodies used were
anti-glial fibrillary acidic protein (GFAP) (rabbit polyclonal,
dilution 1:500; Dako North America Inc.), anti-nestin (chicken
polyclonal, dilution 1:1000; Bio-Techne, Minneapolis, MN,
USA), SOX10 (goat polyclonal, dilution 1:50; Santa Cruz
Biotechnology, Inc., Dallas, TX, USA), beta-3 tubulin (mouse
polyclonal, dilution 1:1000; Thermo Fisher Scientific), and
anti-alpha smooth muscle actin (SMA) (mouse monoclonal,
dilution 1:400; BioLegend, San Diego, CA, USA). Then, sec-
ondary antibodies Alexa Fluor 488 donkey anti-rabbit (1:300;
Jackson Immunoresearch Laboratory), Alexa Fluor 488 don-
key anti-chicken (1:300; Jackson Immunoresearch Laboratory),
Alexa Fluor 555 donkey anti-goat (1:500; Thermo Fisher
Scientific), Alexa Fluor 488 donkey anti-mouse (1:300;
Jackson Immunoresearch Laboratory), and Alexa Fluor
647 donkey anti-mouse (1:500; Thermo Fisher Scientific),
respectively, were added. Nuclei were stained with Hoechst
(1:10,000; Thermo Fisher Scientific) and coverslips mounted
with Fluorescence Mounting Medium (Dako North America
Inc.). To evaluate the differentiation capacity in the CD271þ
population, the fraction of differentiated cells was counted in
five non-overlapping microscopic fields for each coverslip
in three separate experiments (n¼ 3). One CD271-cell
fraction was evaluated as control. Values are expressed
as means ± SEM.
Confocal imaging
Images were obtained by confocal microscope Zeiss LSM 780
(Carl Zeiss Microscopy GmbH, Jena, Germany). For image
analysis, Zeiss ZEN software (blue edition) was used.
Migration assay
Since boundary cap NCSCs are known to migrate toward
islets, the migration behavior of the CD271þ cells was eval-
uated. CD271þ cells were co-cultured with either human
islets or human ICC derived from pluripotent stem cells. A
drop of approximately 50,000 cells and 2–3 islets were
placed on opposite sides of a coverslip placed in a 4-well
plate at a distance of approximately 1000 mm. The cells were
cultured in medium suitable for islet culture. Coverslips were
pretreated with Laminin LN521 (BioLamina AB, Sundbyberg,
Sweden) for 2 h at 37 C in 5% CO2 and 95% air. To visualize
the cells, they were stained with CellTracker Fluorescent
Probes (1:1000; Green CMFDA; Thermo Fisher Scientific).
Images were taken on days 1–7 of co-culture, and the
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distance between cells and islets or ICC was measured.
Experiments were repeated with three biological replicates,
and the migration capacity toward human islets and ICC was
compared and evaluated by measuring the distance to the
CD271þ cells.
Sphere-forming capacity
The ability of the CD271þ human bone marrow cells to form
free-floating 3-dimensional spheres from single cells was
investigated. A single cell suspension was prepared using
TrypLE Express (Thermo Fisher Scientific), and the cells were
transferred to a low-adhesion 6-well plate (Corning, Corning,
NY, USA) for further culture using the same culture condi-
tions as described above.
Results
Morphological characterization of ICC
For morphological characterization of the cells generated
with the modified differentiation protocol, we performed
immunostainings of ICC for pancreatic islet markers. It was
found that the ICC expressed insulin, glucagon, and somato-
statin (Figure 1).
Magnetic cell separation
A primary population of human bone marrow stromal cells
was subsequently cultured for 2 weeks before CD271 mag-
netic cell separation was performed. The primary population
consisted of a heterogeneous population and a small fraction
of CD271þ cells (Figure 2(A)). By using the CD271 magnetic
cell separation method, we were able to obtain a CD271-
enriched population of bone marrow stromal cells (Figure
2(B)). The fraction of CD271þ cells in the primary population
of human bone marrow stromal cells was 1.9% ±
0.6% (n¼ 5).
Differentiation capacity
After only 1 week of culture in medium promoting differenti-
ation, there were cells with different morphological appear-
ances in the CD271þ cultures. There were small spindle cells,
much like glia cells. Moreover, cells with long processes like
neurons as well as large flattened cells consistent with myofi-
broblasts were observed, all with different levels of protein
expression. Cells in the CD271þ population expressed both
GFAP and beta-3 tubulin (Figure 3). However, there was a
noteworthy difference in the differentiation capacity between
donors. Quantification of the immunocytochemical staining
from three different donors showed that GFAP expression
Figure 1. Characterization of human stem cell-derived ICC. Representative images of a sectioned islet-like cell cluster (stage 7) stained for insulin (A, green), gluca-
gon (B, red), and somatostatin (C, yellow). Hoechst-staining is shown in blue (D). Overlay image of images A–D is shown in E. Scale bar, 50 mm.
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was found in 24% ± 10% of the cells, and beta-3 tubulin
expression was found in 25% ± 7% of cells. The CD271- cells
were not able to differentiate, neither into glia cells nor neu-
rons, showing no expression of GFAP nor beta-3 tubulin,
respectively, although cultured under the same conditions
(Figure 3). Both CD271þ and CD271 cell fractions were
able to differentiate into myofibroblasts being positive for
SMA, when cultured under neural differentiation conditions
(Figure 3). In our cell cultures, nestin expression was present
in most of the cells of all three donors in the CD271þ popu-
lation, and the same held true for the CD271 population.
However, the level of expression varied in the culture and
was considerably higher in the CD271þ population (Figures
4 and 5). There was no expression of early neural crest tran-
scription factor SOX10 in either population (data not shown).
Migration
The CD271þ cells migrated toward the human islets as well
as the human ICC when kept in co-culture. During the fol-
lowing days, the distance between the cells and islets or ICC
decreased. Within the first day of co-culture, the cells had
attached to the laminin-coated coverslips, and by day 3 they
had migrated more than half the distance toward the islets
or ICC (Figure 6(B,E)). We found that the cells reached and
started to enfold the islets as well as the ICC within 7 days
of co-culture (Figure (C,F)). There was no obvious difference
in migration behavior toward islets and ICC (Figure 7).
Sphere formation
Within just a couple of days of culture under non-adherent
conditions, 3-dimensional spheres started to form from single
cells. After 2 weeks of culture, the vast majority of cells had
formed spheres (Figure 8).
Discussion
The ultimate goal of this study was to find an adult human
source of cells with similar characteristics as murine bound-
ary cap NCSCs. Such cells should have the ability to be easily
harvested and expanded for the purpose of using them in
clinical islet transplantation to improve the survival and func-
tion of the transplant. In the present study, we demonstrate
a successful method for isolation of NCSC-like cells from
human bone marrow, opening the possibility of autologous
transplantation. The cells were classified as NCSC-derived
based on their tri-lineage differentiation (neurons, glial cells,
and myofibroblast) as well as their ability to form spheres,
further proving their clonogenic potential.
Previous studies have shown the importance of the neural
crest and derivatives to the pancreatic development includ-
ing regulating the size of the beta cell mass and may there-
fore play a natural role in protecting the pancreatic islets
(36). Neural crest stem cells also express angiogenic and
neurogenic factors such as vascular endothelial growth fac-
tor-a (VEGF-a) and glial-derived neurotrophic factor (GDNF),
which have been shown to stimulate beta cell proliferation
and increase islet survival post-transplantation (19,37,38).
These findings indicate that the use of NCSCs as a cellular
therapy could be especially beneficial.
A limited number of studies have previously reported the
presence of cells with neural crest-associated characteristics
in human bone marrow (23,39). The existence of inter-donor
variability of neural expression has previously been reported
as well and might influence reproducibility in clinical settings
(39). These studies have merely cultured the bone marrow
stromal cells under mesenchymal stem cell conditions before
conducting experiments. To overcome this problem and to
purify a NCSC-like population of human bone marrow we
explored the possibility of using CD271 antibodies to isolate
a NCSC-enriched population as well as using media compos-
ition promoting the propagation of NCSCs. Indeed, we iso-
lated a population with a higher differentiation capacity to
Figure 2. P75-staining of the bone marrow stromal cell culture before (A, green) and after (B, green) CD271 magnetic cell separation. Nuclei were counterstained
with Hoechst (blue). The fraction of cells staining positive for P75 after CD271 magnetic cell separation was substantially increased. Scale bar, 50 mm.
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neurons and glia cells, but the difference between donors
was still noteworthy. However, the majority of the cells in
the CD271þ population were nestin-positive. It has been
suggested that nestin expression is a prerequisite for neural
differentiation (40). Furthermore, during maturation nestin
expression is replaced by cell type-specific expression such
as GFAP (41). Therefore, it is possible that if we had cultured
our cells under differentiation conditions for a longer time
period there might have been an even higher differentiation
potential and subsequently lower nestin expression.
SOX10 is a well-accepted NCSC-marker in mice, so it is
noteworthy that no expression of SOX10 was observed.
Several studies attempting to acquire NCSCs from adult
human tissues, such as oral mucosa and gingival tissue, do
not reference any SOX10 expression when characterizing the
obtained NCSCs (29,42). It has also been demonstrated that
NCSCs from human hair follicles express SOX10 during emi-
gration from follicles, suggesting that post-migratory cells
lose their expression (43). Thus, the absence of SOX10 is rea-
sonable in this case.
Figure 3. Immunocytochemical characterization of CD271þ (A, C, E) and CD271- (B, D, F) bone marrow stromal cells. CD271- cells were able to differentiate into
smooth muscle cells, showing positive expression of SMA (B, red), but showed little or no expression of beta-3 tubulin and GFAP, and were thus unable to differen-
tiate into neurons and glia cells, respectively. The CD271þ cells expressed SMA (A, red), beta-3 tubulin (C, green), and GFAP (E, green). Nuclei were counterstained
with Hoechst (blue). Scale bar in A, B, D, E, and F, 50 mm. Scale bar in C, 20 mm.
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Furthermore, we were able to demonstrate a tendency of
mutual migration between CD271þ cells and islets when
kept in co-culture, further demonstrating their similarities
with murine boundary cap NCSCs. The mechanism by which
the NCSCs exert their positive effects on beta cells is not
fully understood. However, studies suggest that some of the
positive effects of murine boundary cap NCSCs, for instance
beta cell proliferation as well as protection against cytokine
induced cell death, are exerted only in direct contact with
islets (35,44). In vitro studies showed that beta cells and
NCSCs formed cadherin junctions, and it is believed that
these mediate some of the positive effects of the NCSCs.
Furthermore, previous studies have shown that islets pro-
mote NCSC migration, indicating that cadherin junctions may
develop as a result of mutual migration by NCSCs and
islets (30,31).
To evaluate whether our NCSC-derived bone marrow cells
have similar migrating features as murine boundary cap
NCSCs, we investigated whether these cells had the ability to
migrate toward islets in vitro. For instance, a previous study
investigating co-culture of NCSCs from hair follicles and islets
showed no mutual migration or formation of cadherin junc-
tions and consequently no increase in beta cell proliferation,
demonstrating the importance of mutual migration (30). The
research on inducible pluripotent stem cell (iPS)-derived insu-
lin-producing cells has been rapidly progressing and holds
great promise for the use of autologous ICC as beta cell
replacement therapy within the near future (33). We there-
fore investigated the migration capacity of the CD271þ cells
toward ICC derived from pluripotent stem cells as well. We
show that the CD271þ cells migrate just as well toward
human ICC, suggesting that the NCSC-derived bone marrow
cells could have beneficial effects on ICC as well. Indeed,
extended studies of the effects of NCSCs on islets and ICC
will be required with careful characterization of NCSCs and
islets/ICC before and after co-culture as well as
Figure 4. Nestin is a marker of immature and undifferentiated neuroepithelial cells. It has been suggested that nestin expression is a necessity for differentiation
into neurons and glia cells. This picture demonstrates different levels of nestin expression in CD271þ (A, green) and CD271- (B, green) populations. Nuclei were
counterstained with Hoechst (blue). Scale bar, 100 mm.
Figure 5. A single cell showing co-expression of nestin (A, green) and GFAP (B, red), demonstrating glial differentiation of a nestin-positive cell. C: Merged picture.
Nuclei were counterstained with Hoechst (blue). Scale bar, 50 mm.
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transplantation. This method could also be used to study fur-
ther the functional maturation of ICC and improve trans-
plantation efficiency in the future.
In conclusion, NCSCs prepared from human bone marrow
could possibly enhance the results of clinical islet transplant-
ation. More efficient methods for their isolation and expan-
sion are, however, necessary due to their scarcity in adult
Figure 6. Co-culture of CD271þ cells and islets (A, B, C) or ICC (D, E, F) showed directed migration toward islets as well as ICC. Images were taken at day 1 (A, D),
day 3 (B, E), and day 7 (C, F) of co-culture. CD271þ cells in green; islets and ICC encircled in yellow. Scale bar, 500 mm.
Figure 7. Overview of distance measured between migrating cells and islets
(red) or ICC (green) in co-cultures. The CD271þ cells showed directed migration
toward both islets and ICC, which is essential for stimulation of beta cell prolif-
eration. The distance between the cells was measured at days 1, 3, and 7. The
CD271þ cells were able to reach and enfold both the islets and ICC within 7
days of co-culture. Results are given as means ± SEM (n¼ 3).
Figure 8. Sphere-forming capacity is seen as a classical characteristic of NCSC-
like cells. CD271þ cells were able to form spheres when cultured under non-
adherent conditions. After 14 days in culture, the majority of cells started to
form spheres. Scale bar, 100 mm.
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tissues. Here, we demonstrated that separation of human
bone marrow cells labeled with CD271 allows for the selec-
tion of cells with functional characteristics much like NCSCs
with a higher degree of differentiation into multiple lineages.
Further studies on the interaction between human bone
marrow-derived NCSCs and pancreatic islets with the optimal
goal of improving clinical islet transplantation and future
beta cell replacement therapies using iPS-derived insulin pro-
ducing cells are highly warranted.
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